|
|
Dawnrays Pharmaceutical (Holdings) Limited
Press Releases
Please download the latest "Acrobat Reader" to view the PDF.
| 2011-December-20 |
Press Release (Chinese Version) (in PDF) |
| 2011-August-22 |
Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared (in PDF) |
| 2011-March-14 |
Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2010: Net Profit after Tax Jumped 41.0% to RMB 166.84 Million, a Final Dividend of HK$ 0.078 per Share was Declared (in PDF) |
| 2011-March-14 |
Dawnrays Pharmaceutical (Holdings) Limited Levamlodipine Besylate Tablets, a Cardiovascular Therapeutic Drug and Cefprozil Tablets, an Oral Cephalosporin Antibiotic, Have Been Granted Production Approvals from the State Food and Drug Administration (in PDF) |
| 2013 |
2013 Press Releases |
| 2012 |
2012 Press Releases |
| 2010 |
2010 Press Releases |
| 2009 |
2009 Press Releases |
| 2008 |
2008 Press Releases |
| 2006 |
2006 Press Releases |
| 2005 |
2005 Press Releases |
|